Shares of Natco Pharma closed 0.22 per cent lower at ₹807 apiece on the BSE | Photo: X@pharma_natco
Natco Pharma on Friday posted a 60.8 per cent decline in consolidated net profit to ₹202.6 crore during the September quarter, weighed down by a fall in revenues.
The pharma company had reported a net profit of ₹517.9 crore in the corresponding period of the preceding fiscal.
Its revenue from operations declined to ₹967.3 crore in the second quarter of FY27 from ₹1,363 crore a year ago, the company said in a regulatory filing.
Total expenses stood at ₹776.2 crore, down from ₹849.3 crore a year ago, it said.